Pancreaticobiliary duct stenting after endoscopic papillectomy in patients with documented adequate field visibility: A case series

Identification of the ductal orifices and stent placement can be challenging after endoscopic papillectomy. We describe procedural findings, pancreaticobiliary stent placement, and recorded early outcomes in patients with documented adequate postresection field visibility. This retrospective single-center case series reviewed 25 adults who underwent endoscopic papillectomy at Chongqing University Cancer Hospital, China, between May 2023 and May 2025. Twenty-one patients with sufficient procedural documentation were analyzed. Visibility was a retrospective description of the procedural field, not an independent predictor. Biliary and pancreatic stent placement were reported separately, with exact 95% confidence intervals (CIs). No comparison or association analysis was performed. The median age was 58 years; 11 patients were male. The median lesion diameter was 16 mm. Endoscopic resection was technically completed in all 21 patients. All included procedures were described as having adequate field visibility, with no documented bleeding that interrupted the procedure or prevented ductal assessment. Biliary stents were placed in 21 patients (100%; 95% CI, 83.9-100%), and pancreatic stents were placed in 16 (76.2%; 95% CI, 52.8-91.8%). Five patients received biliary stents alone; the reasons for pancreatic stent omission were not established. Mean procedure time was 58.3 ± 9.3 minutes, and median hospital stay was 3 days. No pancreatitis, delayed bleeding, perforation, cholangitis, intensive care admission, or readmission was documented in the available records within 30 days. All 21 patients completed 30 day follow-up. This selected case series describes biliary and pancreatic stent placement in procedures with documented adequate visibility. It cannot determine whether visibility influences duct access or adverse events. Prospective comparative studies with independently defined visibility measures are needed.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051409
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pancreaticobiliary duct stenting after endoscopic papillectomy in patients with documented adequate field visibility: A case series

Bing Shi, Zhenghui Yang, Lanying He
2 links
Medicine
Gallbladder and Bile Duct Disorders
article

Pancreaticobiliary duct stenting after endoscopic papillectomy in patients with documented adequate field visibility: A case series

Bing Shi, Zhenghui Yang, Lanying He
article en

Abstract

Identification of the ductal orifices and stent placement can be challenging after endoscopic papillectomy. We describe procedural findings, pancreaticobiliary stent placement, and recorded early outcomes in patients with documented adequate postresection field visibility. This retrospective single-center case series reviewed 25 adults who underwent endoscopic papillectomy at Chongqing University Cancer Hospital, China, between May 2023 and May 2025. Twenty-one patients with sufficient procedural documentation were analyzed. Visibility was a retrospective description of the procedural field, not an independent predictor. Biliary and pancreatic stent placement were reported separately, with exact 95% confidence intervals (CIs). No comparison or association analysis was performed. The median age was 58 years; 11 patients were male. The median lesion diameter was 16 mm. Endoscopic resection was technically completed in all 21 patients. All included procedures were described as having adequate field visibility, with no documented bleeding that interrupted the procedure or prevented ductal assessment. Biliary stents were placed in 21 patients (100%; 95% CI, 83.9-100%), and pancreatic stents were placed in 16 (76.2%; 95% CI, 52.8-91.8%). Five patients received biliary stents alone; the reasons for pancreatic stent omission were not established. Mean procedure time was 58.3 ± 9.3 minutes, and median hospital stay was 3 days. No pancreatitis, delayed bleeding, perforation, cholangitis, intensive care admission, or readmission was documented in the available records within 30 days. All 21 patients completed 30 day follow-up. This selected case series describes biliary and pancreatic stent placement in procedures with documented adequate visibility. It cannot determine whether visibility influences duct access or adverse events. Prospective comparative studies with independently defined visibility measures are needed.

MedicineVol. 105(46)
Chongqing University (CN), Changhai Hospital (CN), Chongqing Cancer Hospital (CN)
Good health and well-being
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon